Exodus Point Capital Management, LP Embecta Corp. Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$15.0 - $22.17 $623,340 - $921,296	-41,556 Reduced 51.43%	39,252 $591,000
Q2 2023 Aug 10, 2023	BUY	$21.6 - $30.69 $878,623 - $1.25 Million	40,677 Added 101.36%	80,808 $1.75 Million
Q1 2023 May 11, 2023	BUY	$23.07 - $32.77 $925,822 - $1.32 Million	40,131 New	40,131 $1.13 Million
Q3 2022 Nov 10, 2022	BUY	$24.0 - $33.42 $579,576 - $807,059	24,149 New	24,149 $695,000

403

51.2M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $846M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.